Cocrystal Pharma (COCP) Other Accumulated Expenses (2011 - 2026)
Cocrystal Pharma (COCP) posted Other Accumulated Expenses of $246,000 for Q2 2026, down 55.4% from $552,000 a year earlier and down 40.6% from the prior quarter.
Powered by 
Analysis
Cocrystal Pharma (COCP) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Cocrystal Pharma's Other Accumulated Expenses came in at $901,000, up 92.5% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In prior years, Cocrystal Pharma's Other Accumulated Expenses was $468,000 in FY2024 (-72.3%), $1.69 million in FY2023 (+628.9%), $232,000 in FY2022 (-62.3%) and $615,000 in FY2021 (+107.1%).
- The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q2 2023.
- On a year-over-year basis, Other Accumulated Expenses increased in two of the last eight quarters, with an average decline of 20.6%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2023, with growth of 628.9%; the weakest was Q2 2022, with a decline of 80.2%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $414,000 (Q1 2026), $901,000 (Q4 2025) and $322,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Cocrystal Pharma | 16.00 Mn | -5.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 246,000.00 |
| Mar 31, 2026 | 414,000.00 |
| Dec 31, 2025 | 901,000.00 |
| Sep 30, 2025 | 322,000.00 |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 504,000.00 |
| Mar 31, 2024 | 766,000.00 |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Dec 31, 2022 | 232,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 211,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | 312,000.00 |
API Access
Cocrystal Pharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COCP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "COCP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=COCP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();